The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Urusova L.S.

National Medical Research Center of Endocrinology

Kletskaya I.S.

N.I. Pirogov Russian National Research Medical University

Porubayeva E.E.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Beltsevich D.G.

National Medical Research Center of Endocrinology

Adrenocortical carcinoma: modern concepts of morphological diagnosis and classification

Authors:

Urusova L.S., Kletskaya I.S., Porubayeva E.E., Beltsevich D.G.

More about the authors

Journal: Russian Journal of Archive of Pathology. 2023;85(4): 32‑38

DOI: 10.17116/patol20238504132

Read: 2564 times

Download PDF (RU)
Contact the author
Table of contents

ADRENOCORTICAL CARCINOMA: MODERN CONCEPTS OF MORPHOLOGICAL DIAGNOSIS AND CLASSIFICATION
ADRENOCORTICAL CARCINOMA: MODERN CONCEPTS OF MORPHOLOGICAL DIAGNOSIS AND CLASSIFICATION

To cite this article:

Urusova LS, Kletskaya IS, Porubayeva EE, Beltsevich DG. Adrenocortical carcinoma: modern concepts of morphological diagnosis and classification. Russian Journal of Archive of Pathology. 2023;85(4):32‑38. (In Russ.)
https://doi.org/10.17116/patol20238504132

Подписка 2026 Архив патологии (Russian Journal of Archive of Pathology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Classification of non-small cell lung cancer acco­rding to the WHO 2021: from morphology to personalized therapy. Russian Journal of Archive of Pathology. 2026;(1):60-67
Quality control of immu­nohistochemical studies in Russia in 2025: achievement and prospects. Russian Journal of Archive of Pathology. 2026;(2):59-66
Ciliary body medu­lloepithelioma asso­ciated with fungal endo­phthalmitis (clinical obse­rvation). Russian Annals of Ophthalmology. 2026;(1):87-94
Successful surgical treatment of a patient with loca­lly adva­nced adre­nocortical cancer with prosthetic replacement of the IVC section with cryopreserved allo­graft using a veno­venous bypass shunt. P.A. Herzen Journal of Onco­logy. 2026;(2):59-64
Abstract:

In 2022, the 5th edition of the of the WHO Classification of Tumours of Endocrine Organs was published, which outlines the current understanding of adrenocortical cancer (ACC), resulting from interdisciplinary research over the past decade. This article highlights the new provisions of the WHO classification for the morphological diagnosis of ACC.

Keywords:

adrenocortical cancer
morphological diagnostics
WHO classification

Authors:

Urusova L.S.

National Medical Research Center of Endocrinology

Kletskaya I.S.

N.I. Pirogov Russian National Research Medical University

Porubayeva E.E.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Beltsevich D.G.

National Medical Research Center of Endocrinology

Received:

07.02.2023

Accepted:

19.03.2023

Close metadata

References:

  1. WHO Classification of Tumours Editorial Board. WHO Classification of Tumours. Endocrine tumours. 5th ed. Lyon: IARC; 2022.
  2. Adrenal Cortex. Ch. 10. In: Brierley JD, Gospodarowicz MK, Wittekind C, eds. TNM classification of malignant tumours. 8th ed. Oxford, UK: Wiley Blackwell; 2017;211-214. 
  3. Fassnacht M, Dekkers O, Else T, Baudin E, Berruti A, de Krijger R, Haak HR, Mihai R, Assie G, Terzolo M. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2018;179(4):1-46.  https://doi.org/10.1530/EJE-18-0608
  4. Krivolapov JuA, ed. Makroskopicheskoe issledovanie biopsiinogo i operatsionnogo materiala. Rukovodstvo dlya vrachei-patologoanatomov. M.: Prakticheskaya meditsina; 2020;352. (In Russ.).
  5. Medeiros LJ, Weiss LM. New developments in the pathologic diagnosis of adrenal cortical neoplasms. A review. Am J Clin Pathol. 1992;97(1):73-83.  https://doi.org/10.1093/ajcp/97.1.73
  6. Dehner LP, Hill DA. Adrenal cortical neoplasms in children: why so many carcinomas and yet so many survivors? Pediatr Dev Pathol. 2009;12(4):284-291.  https://doi.org/10.2350/08-06-0489.1
  7. Giordano TJ, Berney D, de Krijger RR, Erickson L, Fassnacht M, Mete O, Papathomas T, Papotti M, Sasano H, Thompson LDR, et al. Data set for reporting of carcinoma of the adrenal cortex: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting. Hum Pathol. 2021;110:50-61.  https://doi.org/10.1016/j.humpath.2020.10.001
  8. Weiss LM. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol. 1984;8(3):163-169.  https://doi.org/10.1097/00000478-198403000-00001
  9. Bisceglia M, Ludovico O, Di Mattia A, Ben-Dor D, Sandbank J, Pasquinelli G, Lau SK, Weiss LM. Adrenocortical oncocytic tumors: report of 10 cases and review of the literature. Int J Surg Pathol. 2004;12(3):231-243.  https://doi.org/10.1177/106689690401200304
  10. Duregon E, Fassina A, Volante M, Nesi G, Santi R, Gatti G, Cappellesso R, Dalino Ciaramella P, Ventura L, Gambacorta M, et al. The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished cases. Am J Surg Pathol. 2013;37(9):1433-1440. https://doi.org/10.1097/PAS.0b013e31828d387b
  11. Pennanen M, Heiskanen I, Sane T, Remes S, Mustonen H, Haglund C, Arola J. Helsinki score — a novel model for prediction of metastases in adrenocortical carcinomas. Hum Pathol. 2015; 46(3):404-410.  https://doi.org/10.1016/j.humpath.2014.11.015
  12. Aubert S, Wacrenier A, Leroy X, Devos P, Carnaille B, Proye C, Wemeau JL, Lecomte-Houcke M, Leteurtre E. Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors. Am J Surg Pathol. 2002;26(12):1612-1619. https://doi.org/10.1097/00000478-200212000-00009
  13. Tkachuk AV, Tertychnyi AS, Bel’tsevich DG, Roslyakova AA, Belousov PV, Selivanova LS. Adrenocortical cancer: morphological variants, immunohistochemical characteristics. Arkhiv Patologii. 2021;83(3):10-18. (In Russ.). https://doi.org/10.17116/patol20218302110
  14. Wieneke JA, Thompson LD, Heffess CS. Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients. Am J Surg Pathol. 2003; 27(7):867-881.  https://doi.org/10.1097/00000478-200307000-00001
  15. Mete O, Gucer H, Kefeli M, Asa SL. Diagnostic and prognostic biomarkers of adrenal cortical carcinoma. Am J Surg Pathol. 2018;42(2):201-213.  https://doi.org/10.1097/PAS.0000000000000943
  16. Martins-Filho SN, Almeida MQ, Soares I, Wakamatsu A, Alves VAF, Fragoso MCBV, Zerbini MCBN. Clinical impact of pathological features including the Ki-67 labeling index on diagnosis and prognosis of adult and pediatric adrenocortical tumors. Endocr Pathol. 2021;32(2):288-300.  https://doi.org/10.1007/s12022-020-09654-x
  17. Duregon E, Molinaro L, Volante M, Ventura L, Righi L, Bolla S, Terzolo M, Sapino A, Papotti MG. Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma. Mod Pathol. 2014;27(9):1246-1254. https://doi.org/10.1038/modpathol.2013.230
  18. Beuschlein F, Weigel J, Saeger W, Kroiss M, Wild V, Daffara F, Libé R, Ardito A, Al Ghuzlan A, Quinkler M, et al. Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. J Clin Endocrinol Metab. 2015;100(3):841-849.  https://doi.org/10.1210/jc.2014-3182
  19. Mete O, Asa SL, Giordano TJ, Papotti M, Sasano H, Volante M. Immunohistochemical biomarkers of adrenal cortical neoplasms. Endocr Pathol. 2018;29(2):137-149.  https://doi.org/10.1007/s12022-018-9525-8
  20. Juhlin CC, Bertherat J, Giordano TJ, Hammer GD, Sasano H, Mete O. What did we learn from the molecular biology of adrenal cortical neoplasia? From histopathology to translational genomics. Endocr Pathol. 2021;32(1):102-133.  https://doi.org/10.1007/s12022-021-09667-0
  21. Selivanova LS, Roslyakova AA, Bogolyubova AV, Tertychnyi AS, Bel’tsevich DG, Abrosimov AJu, Mel’nichenko GA. Molecular genetic markers and criteria for the prediction of adrenocortical carcinoma. Arkhiv Patologii. 2019;81(5):92-96. (In Russ.). https://doi.org/10.17116/patol20198105192
  22. Picard C, Orbach D, Carton M, Brugieres L, Renaudin K, Aubert S, Berrebi D, Galmiche L, Dujardin F, Leblond P, et al. Revisiting the role of the pathological grading in pediatric adrenal cortical tumors: results from a national cohort study with pathological review. Mod Pathol. 2019;32(4):546-559.  https://doi.org/10.1038/s41379-018-0174-8
  23. Domènech M, Grau E, Solanes A, Izquierdo A, Del Valle J, Carrato C, Pineda M, Dueñas N, Pujol M, Lázaro C, et al. Characteristics of adrenocortical carcinoma associated with Lynch syndrome. J Clin Endocrinol Metab. 2021;106(2):318-325.  https://doi.org/10.1210/clinem/dgaa833
  24. Araujo-Castro M, Pascual-Corrales E, Molina-Cerrillo J, Alonso-Gordoa T. Immunotherapy in adrenocortical carcinoma: predictors of response, efficacy, safety, and mechanisms of resistance. Biomedicines. 2021;9(3):304.  https://doi.org/10.3390/biomedicines9030304
  25. Georgantzoglou N, Kokkali S, Tsourouflis G, Theocharis S. Tumor microenvironment in adrenocortical carcinoma: barrier to immunotherapy success? Cancers (Basel). 2021;13(8):1798. https://doi.org/10.3390/cancers13081798
  26. Volante M, Terzolo M, Fassnacht M, Rapa I, Germano A, Sbiera S, Daffara F, Sperone P, Scagliotti G, Allolio B, et al. Ribonucleotide reductase large subunit (RRM1) gene expression may predict efficacy of adjuvant mitotane in adrenocortical cancer. Clin Cancer Res. 2012;18(12):3452-3461. https://doi.org/10.1158/1078-0432.CCR-11-2692
  27. Ronchi CL, Sbiera S, Volante M, Steinhauer S, Scott-Wild V, Altieri B, Kroiss M, Bala M, Papotti M, Deutschbein T, et al. CYP2W1 is highly expressed in adrenal glands and is positively associated with the response to mitotane in adrenocortical carcinoma. PLoS One. 2014;9(8):e105855. https://doi.org/10.1371/journal.pone.0105855
  28. de Reyniès A, Assié G, Rickman DS, Tissier F, Groussin L, René-Corail F, Dousset B, Bertagna X, Clauser E, Bertherat J. Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival. J Clin Oncol. 2009;27(7):1108-1115. https://doi.org/10.1200/JCO.2008.18.5678
  29. Giordano TJ, Kuick R, Else T, Gauger PG, Vinco M, Bauersfeld J, Sanders D, Thomas DG, Doherty G, Hammer G. Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clin Cancer Res. 2009;15(2):668-676.  https://doi.org/10.1158/1078-0432.CCR-08-1067
  30. Assié G, Letouzé E, Fassnacht M, Jouinot A, Luscap W, Barreau O, Omeiri H, Rodriguez S, Perlemoine K, René-Corail F, et al. Integrated genomic characterization of adrenocortical carcinoma. Nat Genet. 2014;46(6):607-612.  https://doi.org/10.1038/ng.2953
  31. Chabre O, Libé R, Assie G, Barreau O, Bertherat J, Bertagna X, Feige JJ, Cherradi N. Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients. Endocr Relat Cancer. 2013;20(4):579-594.  https://doi.org/10.1530/ERC-13-0051
  32. Soon PS, Tacon LJ, Gill AJ, Bambach CP, Sywak MS, Campbell PR, Yeh MW, Wong SG, Clifton-Bligh RJ, Robinson BG, et al. miR-195 and miR-483-5p identified as predictors of poor prognosis in adrenocortical cancer. Clin Cancer Res. 2009;15(24):7684-7692. https://doi.org/10.1158/1078-0432.CCR-09-1587
  33. Barreau O, Assié G, Wilmot-Roussel H, Ragazzon B, Baudry C, Perlemoine K, René-Corail F, Bertagna X, Dousset B, Hamzaoui N, et al. Identification of a CpG island methylator phenotype in adrenocortical carcinomas. J Clin Endocrinol Metab. 2013; 98(1):174-184.  https://doi.org/10.1210/jc.2012-2993
  34. Mohan DR, Lerario AM, Else T, Mukherjee B, Almeida MQ, Vinco M, Rege J, Mariani BMP, Zerbini MCN, Mendonca BB, et al. Targeted assessment of G0S2 methylation identifies a rapidly recurrent, routinely fatal molecular subtype of adrenocortical carcinoma. Clin Cancer Res. 2019;25(11):3276-3288. https://doi.org/10.1158/1078-0432.CCR-18-2693
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.